Azathioprine — clinical trials using this drug

Public-registry trials using Azathioprine that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.

Azathioprine appears in 1 registered trial Eichor's radar has found, sponsored by Ampel BioSolutions, LLC, the most recent registered as Phase 2, with a planned enrollment of 132. Registered timeline: 2015–2020. The registry holds 405 registered studies for Gout.

Trial	Sponsor	Condition	Phase	Sites
Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect	Ampel BioSolutions, LLC	Gout	PHASE2	11

About this study

Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect

Status	Completed · planned start 2015-12
Primary completion	2020-04
Enrollment target	132 participants
Design	Non Randomized · Single Group · Phase 2 · 6 arms
Who it enrolls	All sexes · 18 Years and older — full criteria are on the study record
Locations	11 listed in United States

All fields verbatim from the ClinicalTrials.gov record for NCT02598596.

Origin & regulatory history

First FDA approval	IMURAN — March 1968 (application NDA016324, currently held by LEGACY)
Approval timeline	IMURAN 1968 (LEGACY) → AZATHIOPRINE SODIUM 1995 (HIKMA) → AZATHIOPRINE 1996 (AMNEAL) → AZASAN 1999 (AAIPHARMA LLC)
Also known as	IMURAN · AZATHIOPRINE SODIUM · AZASAN
Approved applications	8 — a multi-source (generic) drug
Forms & routes	Tablet, Injectable · Oral, Injection
Registry-wide use	316 registered studies all-time · 37 currently recruiting

Sources: FDA Drugs@FDA and ClinicalTrials.gov, public records. The application holder shown is the current holder, which may differ from the original developer.

Gout drug landscape

The public registry holds 405 registered studies for Gout. Compounds appearing across the 200 most recently updated registry entries:

Placebo ×35 Febuxostat ×17 Allopurinol ×13 Colchicine ×12 AR882 ×11 F-02-2-Na ×9 Methotrexate ×8 Dotinurad ×7 Pegloticase ×7 F-02-2-Na Matching Placebo ×6 SHR4640 ×5 Epidemiological study ×4 Febuxostat placebo ×4 Tigulixostat ×4 ABP-671 ×3 ABP-745 ×3 Genakumab for ×3 Metformin ×3 Phase 1b: HZBio1 ×3 Phase 2: HZBio1 ×3 SAP-001 ×3 SIBP-R002 ×3 Usual Care ×3 ALLN-346 ×2 AR882 Placebo ×2 Compound Betamethasone ×2 D-0120 ×2 Epaminurad ×2 Epaminurad placebo ×2 etoricoxib ×2

Free site-risk snapshot for any of these trials

Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Related drugs & trials

Trialed alongside

Pegloticase

Other Gout drugs

← Eichor home · All tracked trials · Gout studies · Weekly briefs

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →